TCR2 THERAPEUTICS INC. 3 SEC Filings

Filed On	Filing
05 May 2023	Form 3: Tang Kevin C, 10% owner and 2 others Holds 3,926,287 shares of Common Stock
27 Jun 2022	Form 3: Sullivan Eric, Chief Financial Officer No securities owned
12 Jan 2022	Form 3: Harrison Rosemary, Chief Business & Strategy No securities owned
26 Aug 2021	Form 3: Hegde Priti, Director No securities owned
27 Jul 2021	Form 3: Olagunju Peter, Chief Technical Officer Holds 2,192 shares of Common Stock
04 Feb 2021	Form 3: Tomasello Shawn, Director No securities owned
04 May 2020	Form 3: Webster Stephen W, Director No securities owned
15 Apr 2020	Form 3: Hoos Axel, Director No securities owned
27 Mar 2020	Form 3: Justice Angela, Chief People Officer
13 Feb 2019	Form 3: Redmile Group, Llc, 10% owner and 1 other
13 Feb 2019	Form 3: Ubs Oncology Impact Fund L.p., 10% owner and 3 others
13 Feb 2019	Form 3: Mpm SunStates Fund, L.p., 10% owner and 3 others Holds 195,902 shares of Common Stock
13 Feb 2019	Form 3: Mpm BioVentures 2014, L.p., 10% owner and 7 others Holds 195,902 shares of Common Stock
13 Feb 2019	Form 3: Upnorth Investment Ltd, 10% owner and 2 others
13 Feb 2019	Form 3: Hofmeister Robert, Chief Scientific Officer Holds 24,137 shares of Common Stock
13 Feb 2019	Form 3: Gadicke Ansbert, Director Holds 195,902 shares of Common Stock
13 Feb 2019	Form 3: Menzel Garry E, Director Holds 84,527 shares of Common Stock
13 Feb 2019	Form 3: Jovan-Embiricos Morana, Director and 6 others
13 Feb 2019	Form 3: Somaiya Mayur Ian, Chief Financial Officer
13 Feb 2019	Form 3: Gibson Neil W, Director

Comments